dapagliflozin brands
18 registered brands containing dapagliflozin in South Africa.
Dapagliflozin
PubChem CID 9887712Molecular formula: C21H25ClO6
Dapagliflozin inhibits the sodium-glucose cotransporter 2(SGLT2) which is primarily located in the proximal tubule of the nephron. SGLT2 facilitates 90% of glucose reabsorption in the kidneys and so its inhibition allows for glucose to be excreted in the urine. This excretion allows for better glycemic control and potentially weight loss in patients with type 2 diabetes mellitus.
Source: PubChem (NCBI) ยท compound 9887712
All countries
Kenya
Tanzania
Rwanda
Zambia
Uganda
Malawi
South Africa
Zimbabwe
Nigeria
Ghana
Botswana
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| DAPACARO 10 | - | Registered | South Africa |
| DAPACARO 5 | - | Registered | South Africa |
| DAPADYN 10 mg | - | Registered | South Africa |
| DAPADYN 5 mg | - | Registered | South Africa |
| DAPAGLIFLOZIN 10 mg PD | - | Registered | South Africa |
| DAPAGLIFLOZIN 10 SANDOZ | - | Registered | South Africa |
| DAPAGLIFLOZIN 5 mg PD | - | Registered | South Africa |
| DAPAGLIFLOZIN 5 SANDOZ | - | Registered | South Africa |
| REDIFARG XR 10 mg/1 000 mg | - | Registered | South Africa |
| REDIFARG XR 10 mg/500 mg | - | Registered | South Africa |
| REDIFARG XR 5 mg/1 000 mg | - | Registered | South Africa |
| REDIFARG XR 5 mg/500 mg | - | Registered | South Africa |
| SUDAPO 10 | - | Registered | South Africa |
| SUDAPO 5 | - | Registered | South Africa |
| XIGDUO XR 10 mg/ 1000 mg | - | Canceled | South Africa |
| XIGDUO XR 10 mg/ 500 mg | - | Canceled | South Africa |
| XIGDUO XR 5 mg/ 1000 mg | - | Canceled | South Africa |
| XIGDUO XR 5 mg/ 500 mg | - | Canceled | South Africa |